SPIKEVAX BIVALENT
SPIKEVAX BIVALENT
Discontinued
DIN Number
02530252
Drug Class
Human
Market Date
Sep 12, 2022
Company
HC
moderna biopharma canada corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02530252
AIG Number0264021001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BN01 COVID-19, RNA-BASED VACCINE
Product Specifications
Dosage FormDispersion
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
ELASOMERANActive
Strength: 0.05 MG / ML
Monograph: ELASOMERAN
IMELASOMERANActive
Strength: 0.05 MG / ML
Monograph: IMELASOMERAN